{{Infobox medical condition
 | Name            = 甲狀腺髓質癌
 | Image           = Medullary thyroid carcinoma - high mag.jpg
 | Caption         = 甲狀腺髓質癌[[顯微照相|鏡檢圖]]，圖左可以看見[[類澱粉蛋白|類澱粉蛋白]]沉積。[[苏木精-伊红染色|苏木精-伊红染色]]。
 | DiseasesDB      = 
 | ICD10           = {{ICD10|C|73||c|73}}
 | ICD9            = {{ICD9|193}}
 | ICDO            = 
 | OMIM            = 155240
 | MedlinePlus     = 000374
 | eMedicineSubj   = med
 | eMedicineTopic  = 2272
 | MeshID          = D013964
}}
'''甲狀腺髓質癌'''（{{lang|en|Medullary thyroid cancer}}，簡稱'''MTC'''）為一種發源自[[濾泡旁細胞|濾泡旁細胞]]（C細胞）的[[甲狀腺癌|甲狀腺癌]]，可以分泌[[降鈣素|降鈣素]]<ref name=hu>Hu MI, Vassilopoulou-Sellin R, Lustig R, Lamont JP. [http://www.cancernetwork.com/cancer-management-11/chapter05/article/10165/1402668 "Thyroid and Parathyroid Cancers"] in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) [http://www.cancernetwork.com/cancer-management-11/ Cancer Management: A Multidisciplinary Approach]. 11 ed. 2008.</ref>。甲狀腺髓質癌為第三常見的甲狀腺癌症，占甲狀腺癌總數的3%。

大約四分之一的MTC患者是因{{tsl|en|RET proto-oncogene|RET癌前基因}}突變所致，此類癌症稱為家族性甲狀腺髓質癌。若無涉變異，則稱為自發性MTC。當同時合併副甲狀腺及腎上腺髓質腫瘤則稱為{{tsl|en|Multiple endocrine neoplasia type 2|第二型多發性內分泌腫瘤}}（MEN2），該腫瘤於1959首次被發現<ref>{{cite journal |vauthors=Dionigi G, Bianchi V, Rovera F, etal |title=Medullary thyroid carcinoma: surgical treatment advances |journal=Expert Rev Anticancer Ther |volume=7 |issue=6 |pages=877–85 |year=2007 |pmid=17555398 |doi=10.1586/14737140.7.6.877}}</ref>。

==參考文獻==
{{Reflist|30em}}

{{Endocrine gland neoplasia}}

[[Category:甲狀腺癌症|Category:甲狀腺癌症]]